For example, PRSS3 was identified to be downregulated in lung cancer (Zhou et al., 2023) but upregulated in pancreatic cancer (Jiang et al., 2010; Xing et al., 2019), suggesting that it may have different roles depending on the cellular or disease ways. This evidence concerns the gene PRSS3 and familial pancreatic carcinoma.